Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Dorn

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Psychological Bulletin|February 8, 2024
The immediate effect of discrimination on mental health: A meta-analytic review of the causal evidenceChristine Emmer, Julia Dorn, Jutta Mata
Frontiers in Genetics|March 2, 2013
MUTYH DNA glycosylase: the rationale for removing undamaged bases from the DNAEnni Markkanen, Julia Dorn, Ulrich Hübscher
Frontiers in Chemistry|December 13, 2018
Effect of Temperature and Relative Humidity on the Reaction Kinetics of an Oxygen Scavenger Based on Gallic AcidAstrid F Pant, Julia Dorn, Matthias Reinelt
The Journal of Biological Chemistry|January 21, 2014
Regulation of human MutYH DNA glycosylase by the E3 ubiquitin ligase muleJulia Dorn, Elena Ferrari, Ralph Imhof, et al.
Critical Reviews in Clinical Laboratory Sciences|February 5, 2014
Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancersJulia Dorn, Nathalie Beaufort, Manfred Schmitt, et al.
American Journal of Cancer Research|October 17, 2018
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patientsXiaocong Geng, Yueyang Liu, Tobias Dreyer, et al.
Clinical Biochemistry|December 12, 2022
Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancerKonstantina Panoutsopoulou, Yueyang Liu, Margaritis Avgeris, et al.
Clinical Biochemistry|August 27, 2004
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patientsEleftherios P Diamandis, Carla A Borgoño, Andreas Scorilas, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 24, 2026
High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast CancerWeiwei Gong, Yueyang Liu, Natalie Falkenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic markerAndreas Scorilas, Carla A Borgoño, Nadia Harbeck, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Psychological Bulletin|February 8, 2024
The immediate effect of discrimination on mental health: A meta-analytic review of the causal evidenceChristine Emmer, Julia Dorn, Jutta Mata
Frontiers in Genetics|March 2, 2013
MUTYH DNA glycosylase: the rationale for removing undamaged bases from the DNAEnni Markkanen, Julia Dorn, Ulrich Hübscher
Frontiers in Chemistry|December 13, 2018
Effect of Temperature and Relative Humidity on the Reaction Kinetics of an Oxygen Scavenger Based on Gallic AcidAstrid F Pant, Julia Dorn, Matthias Reinelt
The Journal of Biological Chemistry|January 21, 2014
Regulation of human MutYH DNA glycosylase by the E3 ubiquitin ligase muleJulia Dorn, Elena Ferrari, Ralph Imhof, et al.
Critical Reviews in Clinical Laboratory Sciences|February 5, 2014
Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancersJulia Dorn, Nathalie Beaufort, Manfred Schmitt, et al.
American Journal of Cancer Research|October 17, 2018
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patientsXiaocong Geng, Yueyang Liu, Tobias Dreyer, et al.
Clinical Biochemistry|December 12, 2022
Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancerKonstantina Panoutsopoulou, Yueyang Liu, Margaritis Avgeris, et al.
Clinical Biochemistry|August 27, 2004
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patientsEleftherios P Diamandis, Carla A Borgoño, Andreas Scorilas, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 24, 2026
High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast CancerWeiwei Gong, Yueyang Liu, Natalie Falkenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic markerAndreas Scorilas, Carla A Borgoño, Nadia Harbeck, et al.
Pageof 6